{"id":88147,"date":"2005-09-20T18:19:53","date_gmt":"2005-09-20T16:19:53","guid":{"rendered":"https:\/\/mediarun.com\/index.php\/news-posts\/peppermint-medical-dla-persen\/"},"modified":"2005-09-20T18:19:53","modified_gmt":"2005-09-20T16:19:53","slug":"peppermint-medical-dla-persen","status":"publish","type":"post","link":"https:\/\/mediarun.com\/pl\/trendy\/branding\/peppermint-medical-dla-persen.html","title":{"rendered":"Peppermint Medical dla Persen"},"content":{"rendered":"<p>G\u0142\u00f3wn\u0105 grup\u0119 docelow\u0105 dzia\u0142a\u0144 prowadzonych przez PEPPERMINT MEDICAL stanowi\u0105 pracuj\u0105ce, aktywne kobiety w wieku 25-55 lat, mieszkanki du\u017cych miast, u\u017cywaj\u0105ce leki uspokajaj\u0105ce. Akcja prowadzona b\u0119dzie w aptekach w ca\u0142ej Polsce i potrwa do 30 pa\u017adziernika.<br \/>\nW ramach akcji &#8222;Sprawd\u017a, jak dzia\u0142a Persen&#8221; na rynek zostanie wprowadzona partia  mniejszych opakowa\u0144 leku Persen zawieraj\u0105ce 10 tabletek. Do ka\u017cdego opakowania zostanie do\u0142\u0105czona ulotka informacyjna dla u\u017cytkownik\u00f3w oraz ankieta. Akcja ma bowiem r\u00f3wnie\u017c dostarczy\u0107 odpowiedzi producentowi, jakie opakowania lek\u00f3w uspokajaj\u0105cych preferuj\u0105 klienci. AGENCJA PEPPERMINT MEDICAL przygotowa\u0142a materia\u0142y POS i ulotki dla konsumentek. <\/p>\n","protected":false},"excerpt":{"rendered":"Agencja Peppermint Medical 19 wrze\u015bnia br.  rozpocz\u0119\u0142a akcj\u0119 &#8222;Sprawd\u017a, jak dzia\u0142a Persen&#8221; dla Lek Polska Sp. z o.o. Dzia\u0142ania zwi\u0105zane s\u0105 z wprowadzeniem na rynek ma\u0142ego opakowanie leku Persen (10 tabletek) w cenie 3,99 z\u0142. Celem akcji jest wzrost sprzeda\u017cy i zwi\u0119kszenie \u015bwiadomo\u015bci marki w\u015br\u00f3d Pacjent\u00f3w.","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[9658],"tags":[],"class_list":{"0":"post-88147","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-branding","7":"cs-entry","8":"cs-video-wrap"},"_links":{"self":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/88147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/comments?post=88147"}],"version-history":[{"count":0,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/88147\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media?parent=88147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/categories?post=88147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/tags?post=88147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}